397 related articles for article (PubMed ID: 27049050)
1. Solubility and dissolution enhancement of efavirenz hot melt extruded amorphous solid dispersions using combination of polymeric blends: A QbD approach.
Pawar J; Tayade A; Gangurde A; Moravkar K; Amin P
Eur J Pharm Sci; 2016 Jun; 88():37-49. PubMed ID: 27049050
[TBL] [Abstract][Full Text] [Related]
2. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
3. Study the influence of formulation process parameters on solubility and dissolution enhancement of efavirenz solid solutions prepared by hot-melt extrusion: a QbD methodology.
Pawar J; Suryawanshi D; Moravkar K; Aware R; Shetty V; Maniruzzaman M; Amin P
Drug Deliv Transl Res; 2018 Dec; 8(6):1644-1657. PubMed ID: 29426975
[TBL] [Abstract][Full Text] [Related]
4. Reactive Melt Extrusion To Improve the Dissolution Performance and Physical Stability of Naproxen Amorphous Solid Dispersions.
Liu X; Zhou L; Zhang F
Mol Pharm; 2017 Mar; 14(3):658-673. PubMed ID: 28135108
[TBL] [Abstract][Full Text] [Related]
5. Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus
Albadarin AB; Potter CB; Davis MT; Iqbal J; Korde S; Pagire S; Paradkar A; Walker G
Int J Pharm; 2017 Oct; 532(1):603-611. PubMed ID: 28923766
[TBL] [Abstract][Full Text] [Related]
6. Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement.
Sathigari SK; Radhakrishnan VK; Davis VA; Parsons DL; Babu RJ
J Pharm Sci; 2012 Sep; 101(9):3456-64. PubMed ID: 22437488
[TBL] [Abstract][Full Text] [Related]
7. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
8. Solid crystal suspension of Efavirenz using hot melt extrusion: Exploring the role of crystalline polyols in improving solubility and dissolution rate.
Pawar JN; Fule RA; Maniruzzaman M; Amin PD
Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():1023-1034. PubMed ID: 28575936
[TBL] [Abstract][Full Text] [Related]
9. Solubility and dissolution performances of spray-dried solid dispersion of Efavirenz in Soluplus.
Lavra ZM; Pereira de Santana D; Ré MI
Drug Dev Ind Pharm; 2017 Jan; 43(1):42-54. PubMed ID: 27349377
[TBL] [Abstract][Full Text] [Related]
10. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions.
Guo Z; Lu M; Li Y; Pang H; Lin L; Liu X; Wu C
J Pharm Pharmacol; 2014 Feb; 66(2):285-96. PubMed ID: 24433427
[TBL] [Abstract][Full Text] [Related]
11. Lacidipine Amorphous Solid Dispersion Based on Hot Melt Extrusion: Good Miscibility, Enhanced Dissolution, and Favorable Stability.
Xi L; Song H; Wang Y; Gao H; Fu Q
AAPS PharmSciTech; 2018 Oct; 19(7):3076-3084. PubMed ID: 30094722
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
Andrews GP; AbuDiak OA; Jones DS
J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
[TBL] [Abstract][Full Text] [Related]
13. Hypromellose acetate succinate based amorphous solid dispersions via hot melt extrusion: Effect of drug physicochemical properties.
Sarabu S; Kallakunta VR; Bandari S; Batra A; Bi V; Durig T; Zhang F; Repka MA
Carbohydr Polym; 2020 Apr; 233():115828. PubMed ID: 32059882
[TBL] [Abstract][Full Text] [Related]
14. Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement.
Ponnammal P; Kanaujia P; Yani Y; Ng WK; Tan RBH
Pharmaceutics; 2018 Mar; 10(1):. PubMed ID: 29547585
[TBL] [Abstract][Full Text] [Related]
15. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Biopharmaceutical Performance of Rivaroxaban through Polymeric Amorphous Solid Dispersion.
Metre S; Mukesh S; Samal SK; Chand M; Sangamwar AT
Mol Pharm; 2018 Feb; 15(2):652-668. PubMed ID: 29287144
[TBL] [Abstract][Full Text] [Related]
17. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
18. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
19. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
[TBL] [Abstract][Full Text] [Related]
20. Bottom-Up and Top-Down Approaches to Explore Sodium Dodecyl Sulfate and Soluplus on the Crystallization Inhibition and Dissolution of Felodipine Extrudates.
Chen J; Chen Y; Huang W; Wang H; Du Y; Xiong S
J Pharm Sci; 2018 Sep; 107(9):2366-2376. PubMed ID: 29738699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
